Deal snapshot: Ginkgo Bioworks Acquires Bitome to Accelerate the Path to Production-Ready Organisms.

MANews-(C)2009-2022

Massachusetts, US-based cell programming platform Ginkgo Bioworks (NYSE: DNA) has acquired certain assets from Boston-based integrated metabolite monitoring platform Bitome, to accelerate the path to production-ready organisms, the company said.

Terms of the transaction were not disclosed. Bitome's continuous metabolite...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT